X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 06/Aug 21:15

Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of +50.00% and +17.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Pangaea Logistics (PANL) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 22:30

Pangaea Logistics (PANL) delivered earnings and revenue surprises of +50.00% and +26.65%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Pangaea Logistics (PANL) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 22:30

Pangaea Logistics (PANL) delivered earnings and revenue surprises of +50.00% and +26.65%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 11/Aug 22:55

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +69.37% and +20.84%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 19:00

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 19:00

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:50

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -104.20% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:50

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -104.20% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)

zacks.com - 15/Aug 20:25

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -44.75% and +14.35%, respectively, for the quarter ended June 2025. Do the...

Les derniers communiqués